Doctors continue to refine how breast cancer is treated. Results from a recent clinical trial suggest that further fine-tuning who needs radiation after surgery may be possible.
Trial results showed that adding the targeted therapy drug daratumumab (Darzalex) to standard treatment helped people with newly diagnosed multiple myeloma live longer without their cancer getting worse or dying. People taking daratumumab were also more likely to have no signs of cancer after treatment.
Researchers used computer modeling to estimate the number of deaths that could be prevented, and the harms caused, if more people used recommended cancer screening tests.
Women who have harmful changes in certain genes have a higher risk of some cancers. This updated infographic helps explain the risk of breast cancer for women with harmful BRCA1 and BRCA2 mutations.
Colorectal cancer is cancer that starts anywhere along the colon or rectum. Learn about risk factors, symptoms, and tests to diagnose colorectal cancer in children and how it is treated.
